DK708188A - 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids - Google Patents

5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids

Info

Publication number
DK708188A
DK708188A DK708188A DK708188A DK708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A
Authority
DK
Denmark
Prior art keywords
dideoxy
imino
methyl
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
DK708188A
Other languages
English (en)
Other versions
DK175113B1 (da
DK708188D0 (da
Inventor
Raymond Allen Dwek
Georg William John Fleet
Thomas William Rademacher
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK708188D0 publication Critical patent/DK708188D0/da
Publication of DK708188A publication Critical patent/DK708188A/da
Application granted granted Critical
Publication of DK175113B1 publication Critical patent/DK175113B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK198807081A 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV DK175113B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13621987A 1987-12-21 1987-12-21
US13621987 1987-12-21
US07/249,144 US4999360A (en) 1987-12-21 1988-09-26 Method of inhibiting virus
US24914488 1988-09-26

Publications (3)

Publication Number Publication Date
DK708188D0 DK708188D0 (da) 1988-12-20
DK708188A true DK708188A (da) 1989-06-22
DK175113B1 DK175113B1 (da) 2004-06-07

Family

ID=26834131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198807081A DK175113B1 (da) 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV

Country Status (16)

Country Link
US (1) US4999360A (da)
EP (1) EP0322395B1 (da)
JP (1) JP2538014B2 (da)
KR (1) KR910009994B1 (da)
AT (1) ATE87206T1 (da)
AU (1) AU607834B2 (da)
CA (1) CA1316929C (da)
DE (1) DE3879653T2 (da)
DK (1) DK175113B1 (da)
FI (1) FI93210C (da)
IE (1) IE63095B1 (da)
IL (1) IL88742A (da)
NO (1) NO172340C (da)
NZ (1) NZ227410A (da)
OA (1) OA08937A (da)
PT (1) PT89267B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135346T1 (de) * 1988-11-03 1996-03-15 Searle & Co Dideoxy-l-arabinitol derivate als antivirus- verbindungen
US4894388A (en) * 1988-12-22 1990-01-16 Monsanto Company Glycosidase inhibitors and use thereof
US5100797A (en) * 1989-06-27 1992-03-31 Monsanto Company Fucosidase inhibitors
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
GB9026271D0 (en) * 1990-12-03 1991-01-16 Alphey Thomas J W Control of parasitic nematodes(a)
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
CZ120398A3 (cs) * 1995-09-08 1998-12-16 Novo Nordisk A/S Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty
CN102399228B (zh) * 2010-09-08 2013-10-16 中国科学院成都生物研究所 N-烷基多羟基哌啶衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
WO1987003903A1 (en) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Also Published As

Publication number Publication date
NO172340B (no) 1993-03-29
EP0322395B1 (en) 1993-03-24
EP0322395A1 (en) 1989-06-28
FI885880A0 (fi) 1988-12-20
FI885880L (fi) 1989-06-22
IL88742A0 (en) 1989-07-31
DK175113B1 (da) 2004-06-07
KR910009994B1 (ko) 1991-12-10
FI93210C (fi) 1995-03-10
IE63095B1 (en) 1995-03-22
NO885655L (no) 1989-06-22
KR890009389A (ko) 1989-08-01
AU2706888A (en) 1989-06-22
NZ227410A (en) 1991-06-25
IL88742A (en) 1993-08-18
IE883794L (en) 1989-06-21
ATE87206T1 (de) 1993-04-15
DE3879653D1 (de) 1993-04-29
NO885655D0 (no) 1988-12-20
AU607834B2 (en) 1991-03-14
DE3879653T2 (de) 1993-10-14
JPH01230517A (ja) 1989-09-14
US4999360A (en) 1991-03-12
NO172340C (no) 1993-07-07
CA1316929C (en) 1993-04-27
PT89267B (pt) 1993-12-31
PT89267A (pt) 1989-12-29
JP2538014B2 (ja) 1996-09-25
DK708188D0 (da) 1988-12-20
OA08937A (fr) 1989-10-31
FI93210B (fi) 1994-11-30

Similar Documents

Publication Publication Date Title
AU653972B2 (en) HIV protease inhibitors
DK0396083T3 (da) Heterocykliske N-oxidderivater af substituerede benzo(5,6)-cycloheptapyridiner, præparater og anvendelsesfremgangsmåder
DK708188D0 (da) 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids
NO931867L (no) Aminokinolonderivater substituert med arylgrupper og aromatiske heteocykliske grupper, samt middel mot HIV
MY103352A (en) Piperazinyl-heterocyclic compounds
DK73193D0 (da) Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
DK5389D0 (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
ES2149267T3 (es) Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral.
DK0461079T3 (da) Substituerede phthalider og heterocykliske phthalider
ES2072627T3 (es) Derivados de piridina y n-oxido de piridina de diarilmetilpiperidinas o piperazinas, composiciones y uso de las mismas.
DK0658548T3 (da) Benzensylfonamidderivat og fremgangsmåde til fremstilling deraf
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
DE68927160D1 (de) Verwendung von N-Butyl-Deoxynojirimycin zur Behandlung von Herpes
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ATE123024T1 (de) 4-aminopyridinderivate.
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
IE883793L (en) Method of inhibiting human immunodeficiency virus
DE69200948D1 (de) Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen.
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
UA18634A1 (uk) Спосіб одердаhhя похідhих l-алаhіл-l-пропіліhа або їх фармацевтичhо прийhятhих солей
ATE111462T1 (de) 1,4-dihydropyridin-derivate.
GR930100335A (el) Ενώσεις και μέ?οδοι αναστολής του ΗΙV και των σχετικών ιών.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK